Cargando…
CFTR and Ca(2+) Signaling in Cystic Fibrosis
Among the diverse physiological functions exerted by calcium signaling in living cells, its role in the regulation of protein biogenesis and trafficking remains incompletely understood. In cystic fibrosis (CF) disease the most common CF transmembrane conductance regulator (CFTR) mutation, F508del-CF...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200540/ https://www.ncbi.nlm.nih.gov/pubmed/22046162 http://dx.doi.org/10.3389/fphar.2011.00067 |
_version_ | 1782214700626345984 |
---|---|
author | Antigny, Fabrice Norez, Caroline Becq, Frédéric Vandebrouck, Clarisse |
author_facet | Antigny, Fabrice Norez, Caroline Becq, Frédéric Vandebrouck, Clarisse |
author_sort | Antigny, Fabrice |
collection | PubMed |
description | Among the diverse physiological functions exerted by calcium signaling in living cells, its role in the regulation of protein biogenesis and trafficking remains incompletely understood. In cystic fibrosis (CF) disease the most common CF transmembrane conductance regulator (CFTR) mutation, F508del-CFTR generates a misprocessed protein that is abnormally retained in the endoplasmic reticulum (ER) compartment, rapidly degraded by the ubiquitin/proteasome pathway and hence absent at the plasma membrane of CF epithelial cells. Recent studies have demonstrated that intracellular calcium signals consequent to activation of apical G-protein-coupled receptors by different agonists are increased in CF airway epithelia. Moreover, the regulation of various intracellular calcium storage compartments, such as ER is also abnormal in CF cells. Although the molecular mechanism at the origin of this increase remains puzzling in epithelial cells, the F508del-CFTR mutation is proposed to be the onset of abnormal Ca(2+) influx linking the calcium signaling to CFTR pathobiology. This article reviews the relationships between CFTR and calcium signaling in the context of the genetic disease CF. |
format | Online Article Text |
id | pubmed-3200540 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Frontiers Research Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-32005402011-11-01 CFTR and Ca(2+) Signaling in Cystic Fibrosis Antigny, Fabrice Norez, Caroline Becq, Frédéric Vandebrouck, Clarisse Front Pharmacol Pharmacology Among the diverse physiological functions exerted by calcium signaling in living cells, its role in the regulation of protein biogenesis and trafficking remains incompletely understood. In cystic fibrosis (CF) disease the most common CF transmembrane conductance regulator (CFTR) mutation, F508del-CFTR generates a misprocessed protein that is abnormally retained in the endoplasmic reticulum (ER) compartment, rapidly degraded by the ubiquitin/proteasome pathway and hence absent at the plasma membrane of CF epithelial cells. Recent studies have demonstrated that intracellular calcium signals consequent to activation of apical G-protein-coupled receptors by different agonists are increased in CF airway epithelia. Moreover, the regulation of various intracellular calcium storage compartments, such as ER is also abnormal in CF cells. Although the molecular mechanism at the origin of this increase remains puzzling in epithelial cells, the F508del-CFTR mutation is proposed to be the onset of abnormal Ca(2+) influx linking the calcium signaling to CFTR pathobiology. This article reviews the relationships between CFTR and calcium signaling in the context of the genetic disease CF. Frontiers Research Foundation 2011-10-25 /pmc/articles/PMC3200540/ /pubmed/22046162 http://dx.doi.org/10.3389/fphar.2011.00067 Text en Copyright © 2011 Antigny, Norez, Becq and Vandebrouck. http://www.frontiersin.org/licenseagreement This is an open-access article subject to a non-exclusive license between the authors and Frontiers Media SA, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and other Frontiers conditions are complied with. |
spellingShingle | Pharmacology Antigny, Fabrice Norez, Caroline Becq, Frédéric Vandebrouck, Clarisse CFTR and Ca(2+) Signaling in Cystic Fibrosis |
title | CFTR and Ca(2+) Signaling in Cystic Fibrosis |
title_full | CFTR and Ca(2+) Signaling in Cystic Fibrosis |
title_fullStr | CFTR and Ca(2+) Signaling in Cystic Fibrosis |
title_full_unstemmed | CFTR and Ca(2+) Signaling in Cystic Fibrosis |
title_short | CFTR and Ca(2+) Signaling in Cystic Fibrosis |
title_sort | cftr and ca(2+) signaling in cystic fibrosis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200540/ https://www.ncbi.nlm.nih.gov/pubmed/22046162 http://dx.doi.org/10.3389/fphar.2011.00067 |
work_keys_str_mv | AT antignyfabrice cftrandca2signalingincysticfibrosis AT norezcaroline cftrandca2signalingincysticfibrosis AT becqfrederic cftrandca2signalingincysticfibrosis AT vandebrouckclarisse cftrandca2signalingincysticfibrosis |